Abner Herrman & Brock LLC Horizon Therapeutics Public LTD CO Transaction History

Abner Herrman & Brock LLC

  • $829 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$79.4 - $116.36 $291,795 - $427,623
-3,675 Reduced 10.82%
30,280 $2.42 Million
Q1 2022

Apr 07, 2022
BUY
$86.42 - $109.81 $1.13 Million - $1.43 Million
13,050 Added 62.43%
33,955 $3.57 Million
Q4 2021

Jan 13, 2022
BUY
$98.56 - $119.91 $2.06 Million - $2.51 Million
20,905 New
20,905 $2.25 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Abner Herrman & Brock LLC Portfolio

Follow Abner Herrman & Brock LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email